Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−8.2 SEK
−113.32 M SEK
0.00 SEK
About GUARD THERAPEUTICS INTERNATIONAL AB
Sector
CEO
Tobias Larsson Agervald
Headquarters
Stockholm
Website
Founded
2008
ISIN
SE0021181559
FIGI
BBG004D30VL8
Guard Therapeutics International AB is a pharmaceutical company, which engages in the research, development, and commercialization of medical treatment and diagnosis based on alpha-1-microglobulin. It focuses on the treatment of pre-eclampsia and acute kidney injury. The company was founded by Bo Åkerström, Tomas Jörgen Eriksson, Stefan Hansson, Gram Magnus on April 4, 2008 and is headquartered in Stockholm, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GUARD is 20.8 SEK — it has increased by 11.23% in the past 24 hours. Watch GUARD THERAPEUTICS INTERNATIONAL AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange GUARD THERAPEUTICS INTERNATIONAL AB stocks are traded under the ticker GUARD.
GUARD stock has risen by 14.29% compared to the previous week, the month change is a 9.47% rise, over the last year GUARD THERAPEUTICS INTERNATIONAL AB has showed a −44.83% decrease.
GUARD reached its all-time high on May 12, 2015 with the price of 6,126.2 SEK, and its all-time low was 5.2 SEK and was reached on May 30, 2023. View more price dynamics on GUARD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GUARD stock is 15.56% volatile and has beta coefficient of −0.12. Track GUARD THERAPEUTICS INTERNATIONAL AB stock price on the chart and check out the list of the most volatile stocks — is GUARD THERAPEUTICS INTERNATIONAL AB there?
Today GUARD THERAPEUTICS INTERNATIONAL AB has the market capitalization of 255.73 M, it has decreased by −8.50% over the last week.
Yes, you can track GUARD THERAPEUTICS INTERNATIONAL AB financials in yearly and quarterly reports right on TradingView.
GUARD THERAPEUTICS INTERNATIONAL AB is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
GUARD net income for the last quarter is −31.73 M SEK, while the quarter before that showed −23.87 M SEK of net income which accounts for −32.89% change. Track more GUARD THERAPEUTICS INTERNATIONAL AB financial stats to get the full picture.
No, GUARD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GUARD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUARD THERAPEUTICS INTERNATIONAL AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GUARD THERAPEUTICS INTERNATIONAL AB technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GUARD THERAPEUTICS INTERNATIONAL AB stock shows the sell signal. See more of GUARD THERAPEUTICS INTERNATIONAL AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.